FDA Announces Sentinel Program; Stakeholders Watch For Details

The Department of Health and Human Services unveiled the first phase of FDA's Sentinel post-market safety surveillance initiative with fanfare May 22, but stakeholders will have to wait for details on funding and the timing of a full-scale rollout